These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17609226

  • 1. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M, Smith CJ, Hubbard RB.
    QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
    [Abstract] [Full Text] [Related]

  • 2. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM.
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [Abstract] [Full Text] [Related]

  • 3. Fracture risk associated with systemic and topical corticosteroids.
    Vestergaard P, Rejnmark L, Mosekilde L.
    J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
    [Abstract] [Full Text] [Related]

  • 4. Fracture risk associated with inhaled corticosteroid use in chronic obstructive pulmonary disease.
    Lee TA, Weiss KB.
    Am J Respir Crit Care Med; 2004 Apr 01; 169(7):855-9. PubMed ID: 14711795
    [Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD.
    Joo MJ, Au DH, Fitzgibbon ML, Lee TA.
    Respir Med; 2010 Feb 01; 104(2):246-52. PubMed ID: 19879745
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroids and the risk of atrial fibrillation.
    van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH.
    Arch Intern Med; 2006 May 08; 166(9):1016-20. PubMed ID: 16682576
    [Abstract] [Full Text] [Related]

  • 7. Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study.
    Mortimer KJ, Tata LJ, Smith CJ, West J, Harrison TW, Tattersfield AE, Hubbard RB.
    Thorax; 2006 May 08; 61(5):405-8. PubMed ID: 16517576
    [Abstract] [Full Text] [Related]

  • 8. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].
    Ieda Y, Nagasaka Y.
    Clin Calcium; 2007 Jun 08; 17(6):955-62. PubMed ID: 17548937
    [Abstract] [Full Text] [Related]

  • 9. The population risk of fractures attributable to oral corticosteroids.
    Donnan PT, Libby G, Boyter AC, Thompson P.
    Pharmacoepidemiol Drug Saf; 2005 Mar 08; 14(3):177-86. PubMed ID: 15672413
    [Abstract] [Full Text] [Related]

  • 10. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S, Amin AV, Loke YK.
    Arch Intern Med; 2009 Feb 09; 169(3):219-29. PubMed ID: 19204211
    [Abstract] [Full Text] [Related]

  • 11. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN, Blanchard JF, Metge C, Yogendran M.
    Am J Gastroenterol; 2003 Aug 09; 98(8):1797-801. PubMed ID: 12907335
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
    Sin DD, Golmohammadi K, Jacobs P.
    Am J Med; 2004 Mar 01; 116(5):325-31. PubMed ID: 14984818
    [Abstract] [Full Text] [Related]

  • 13. Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures.
    Vestergaard P, Rejnmark L, Mosekilde L.
    Calcif Tissue Int; 2008 Apr 01; 82(4):249-57. PubMed ID: 18414920
    [Abstract] [Full Text] [Related]

  • 14. High-dose corticosteroid exposure and osteoporosis intervention in adults.
    Che M, Ettinger B, Nguyen MT, Pressman AR, Johnston J.
    Ann Allergy Asthma Immunol; 2006 Oct 01; 97(4):497-501. PubMed ID: 17069105
    [Abstract] [Full Text] [Related]

  • 15. Children and the risk of fractures caused by oral corticosteroids.
    van Staa TP, Cooper C, Leufkens HG, Bishop N.
    J Bone Miner Res; 2003 May 01; 18(5):913-8. PubMed ID: 12733732
    [Abstract] [Full Text] [Related]

  • 16. Inhaled corticosteroids and risk of lung cancer among COPD patients who quit smoking.
    Kiri VA, Fabbri LM, Davis KJ, Soriano JB.
    Respir Med; 2009 Jan 01; 103(1):85-90. PubMed ID: 18793832
    [Abstract] [Full Text] [Related]

  • 17. Alveolar-capillary membrane permeability for early prediction of response of inhaled steroid on patients with chronic obstructive pulmonary disease.
    Chou SH, Chen YW, Chuang HY, Kao EL, Huang MF.
    J Clin Pharm Ther; 2006 Aug 01; 31(4):363-8. PubMed ID: 16882106
    [Abstract] [Full Text] [Related]

  • 18. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.
    Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS, Burge PS, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JB, Szafranski W, Vestbo J.
    Thorax; 2005 Dec 01; 60(12):992-7. PubMed ID: 16227327
    [Abstract] [Full Text] [Related]

  • 19. Use of inhaled corticosteroids and the risk of cataracts.
    Cumming RG, Mitchell P, Leeder SR.
    N Engl J Med; 1997 Jul 03; 337(1):8-14. PubMed ID: 9203425
    [Abstract] [Full Text] [Related]

  • 20. Inhaled and nasal corticosteroid use and the risk of fracture.
    Suissa S, Baltzan M, Kremer R, Ernst P.
    Am J Respir Crit Care Med; 2004 Jan 01; 169(1):83-8. PubMed ID: 14551165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.